The conversation is about finding a clearnet vendor for clascoterone, also known as Winlevi, for hair loss treatment. The user is seeking recommendations via direct message.
A trans woman is using 10 mg oral minoxidil, dutasteride, and estradiol for hair regrowth and is also doing dermastamping despite the pain. Users discuss the benefits of dermastamping for serum absorption and hair follicle stimulation, with some expressing surprise at the high minoxidil dosage.
The conversation discusses hair loss treatments, focusing on Tsuji's hair cloning and Shiseido's RCH-01, with skepticism about their effectiveness on humans. It compares these to PRP, noting PRP's higher efficacy in studies.
PP405 is being discussed as a promising hair loss treatment, potentially effective when combined with minoxidil and pyrilutamide. Some users are skeptical about rapid hair regrowth claims, while others are considering alternatives like GT20029 and pyrilutamide instead of finasteride.
PP405 is ineffective for miniaturized, fibrosed hair follicles in androgenetic alopecia. AMP303 may activate hair follicle stem cells, but minoxidil and finasteride are still the main treatments.
The conversation is about finding a reputable hair transplant clinic in Tijuana for crown restoration, with a focus on ethical practices and preserving the donor area. The user has been using finasteride and minoxidil for almost four years and seeks a skilled surgeon to avoid hair mills.
A user shared progress pictures after 5 months of using Dutasteride 0.5 mg and Minoxidil 2.5 mg, with a hair transplant planned for August 2027. Suggestions included increasing Minoxidil dosage and considering Finasteride if results are not satisfactory.
The user reported high testosterone and estradiol levels within range, but unexpectedly high DHT levels after using finasteride and dutasteride for hair loss. Another person suggested the dutasteride might be fake or a bad batch and recommended using the branded Avodart.
PP405 and JXL-069 are the same compound, but users experienced no results due to flawed application methods. The topical gel formulation of PP405 is designed to target hair follicle stem cells effectively, unlike liquid solutions that fail to penetrate deeply.
A new hair loss treatment, PP405, is moving from phase 2A to 2B in clinical trials, sparking discussions about its potential to regrow dormant hairs and its impact on existing treatments like Minoxidil and finasteride. Some users express skepticism, while others are hopeful about its future effectiveness.
PP405 was ineffective for hair growth as some follicles were already active before treatment, raising doubts about its efficacy. Users discussed other hair loss treatments like Minoxidil, finasteride, and RU58841, expressing skepticism and hope for future solutions.
Many users experienced increased diffuse thinning after starting finasteride, with some switching to dutasteride or adding minoxidil in hopes of improvement. Thyroid issues and low ferritin levels were also discussed as potential factors affecting hair loss.
User Kylo313 used dutasteride for 20 years and had two daughters, questioning if dutasteride affects the likelihood of having male vs female children. Replies mostly request hairline photos and discuss anecdotal experiences, with some suggesting correlation doesn't imply causation and that gender determination isn't affected by dutasteride.
The conversation is about finding a suitable hairbrush for diffuse thinning hair without causing separation or flattening. The user is using oral dutasteride, minoxidil foam, Nizoral, microneedling, and Pura D’or shampoo and conditioner.
The conversation humorously critiques hair loss treatments and the subreddit r/tressless. It mentions Minoxidil and finasteride as common treatments, with users reacting to a satirical roast by ChatGPT.
The user has been treating hair loss with oral finasteride and minoxidil since September 2025 and is considering a hair transplant due to diffuse thinning. Other users suggest adding a topical treatment and share their own experiences with similar treatments, including oral minoxidil and dutasteride.
The user has been using oral finasteride and minoxidil since mid-April and sees progress on the crown but not the front, considering a hair transplant. Suggestions include continuing medication, adding microneedling, and possibly getting a hair transplant for areas with no hair.
Minoxidil and finasteride are discussed for hair loss, with concerns about minoxidil's heart-related side effects. New treatments like PP405 are met with skepticism, often humorously noted as always being "five years away."
Triple Hair Inc. developed a new topical treatment, TH07, combining Finasteride, Latanoprost, and Minoxidil for androgenic alopecia. Users discussed its effectiveness compared to other treatments and shared their own product combinations.
The user shared progress on hair regrowth using oral dutasteride, oral minoxidil, and verteporfin procedures. They reported some regrowth after 6-9 months of treatment.
Dutasteride is used for hair regrowth, with some users experiencing side effects like reduced libido, changes in semen consistency, and emotional effects. Some users report positive hair regrowth results, while others experience issues like gynecomastia and fat accumulation.
PP405 is considered a promising hair loss treatment, potentially replacing minoxidil but not finasteride. Users are hopeful for future treatments like GT20029 and VDPHL01, while remaining cautious about effectiveness and side effects.
Dutasteride has significantly improved hair growth for the user, especially at the temples and back of the head, after six months of use. The user is considering stopping minoxidil due to its limited effectiveness and inconvenience, while others caution against stopping it abruptly.
The user has been using finasteride for 3 years with good results and wants to switch to dutasteride combined with tamsulosin. They are seeking more information about tamsulosin.
PP405 aims to reactivate hair follicle stem cells to promote hair growth, but its effectiveness is debated. Some users are skeptical, citing past failures of similar treatments and questioning the company's claims.
The conversation discusses the idea of naturally lowering testosterone levels to potentially reduce DHT and help with hair loss, though it is speculative and not tested by the original poster. Participants suggest using treatments like finasteride, dutasteride, or RU58841 instead, as they directly target DHT without reducing testosterone.
A user shares progress on hair thickening using finasteride, minoxidil, RU58841, and dermastamping. Another user notes slow but ongoing improvement with a similar treatment routine.
The conversation discusses hair loss treatments, specifically topical dutasteride, minoxidil, and finasteride. Users share experiences and opinions on the effectiveness and side effects of these treatments.
A bodybuilder uses 1400mg testosterone weekly, 400mg equipoise, and GH, with 0.5mg dutasteride daily to stabilize hair loss and manage DHT levels. The user reports no side effects from dutasteride and finds it effective, while also discussing costs and effectiveness of other treatments like RU58841 and minoxidil.
The conversation is about the lack of updates on GT20029, a potential hair loss treatment, and the user considering using dutasteride or RU58841 instead of minoxidil/finasteride due to the long duration of the latter treatments.